Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Azide | HCID 33557 | — |
| Reactant | Azide | HCID 33558 | — |
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | p-Toluenesulfonate | HCID 85570 | — |
| Reactant | Benzo[b]furan-2-boronic acid | HCID 2776266 | — |
| Reactant | (+/-)-(7-{[(Trifluoromethyl)sulfonyl]oxy}-2,3-dihydro-1-benzofuran-2-yl)methyl 4-methylbenzenesulfonate | HCID 86599077 | — |
| Reactant | HCID 86599195 | HCID 86599195 | — |
| Reactant | HCID 86599196 | HCID 86599196 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Product | HCID 68963792 | HCID 68963792 | 34.3% |
Reaction Steps
Treatment of (±)-(7-{[(trifluoromethyl)sulfonyl]oxy}-2,3-dihydro-1-benzofuran-2-yl)methyl 4-methylbenzenesulfonate (1.5 g, 3.32 mmol) with 2-benzofuranboronic acid (0.81 g, 4.97 mmol), tetrakis(triphenylphosphine)palladium(0) (0.38 g, 0.33 mmol), and potassium phosphate (1.41 g, 6.63 mmol) generally according to the procedure described for Intermediate 50 provided (±)-2′,3′-dihydro-2,7′-bi-1-benzofuran-2′-ylmethyl 4-methylbenzenesulfonate. Treatment of the tosylate with sodium azide (0.09 g, 1.32 mmol) generally according to the procedure described for Intermediate 98 afforded (±)-2′-(azidomethyl)-2′,3′-dihydro-2,7′-bi-1-benzofuran. Treatment of the azide with palladium on carbon (0.03 g, 10 wt. %) generally according to the procedure described for Example 1 provided 0.12 g (12%) of (±)-1-(2′,3′-dihydro-2,7′-bi-1-benzofuran-2′-yl)methanamine as a white solid, hydrochloride salt. mp >220° C. (dec); Anal. calcd. for C19H17NOHCl.1.0H2O: C, 63.85; H, 5.67; N, 4.38. Found: C, 63.54; H, 5.1; N, 4.3.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07435837B2 |
|---|
| Source dataset | uspto-grants-2008_10 |
|---|
| ORD ID | ord-27e8d113a2434fec9048ae86e0d23dfc |
|---|
| Source note | uspto-grants-2008_10 |
|---|